Ticker League

FCF Margin for Regeneron Pharmaceuticals (REGN)

As of · Reported

Metric

TTM

27.9%

YoY change

+2.65pp

Trough year (2002)

-659.0%

Peak year (2021)

40.6%

FCF Margin history chart for Regeneron Pharmaceuticals (REGN) from 1991 to 2025

Latest: 28.4%

FCF Margin change chart for Regeneron Pharmaceuticals (REGN) from 1991 to 2025

Latest: +2.65pp

FCF Margin history table for Regeneron Pharmaceuticals (REGN) from 1991 to 2025

  • 202528.4%+2.65pp
  • 202425.8%-2.16pp
  • 202328.0%-8.39pp
  • 202236.3%-4.28pp
  • 202140.6%+17.05pp
  • 202023.6%-6.93pp
  • 201930.5%+3.50pp
  • 201827.0%+9.38pp
  • 201717.6%-2.42pp
  • 201620.0%+4.13pp
  • 201515.9%+1.03pp
  • 201414.9%-5.66pp
  • 201320.5%+29.53pp
  • 2012-9.0%+35.62pp
  • 2011-44.6%-43.89pp
  • 2010-0.7%+43.98pp
  • 2009-44.7%+7.27pp
  • 2008-52.0%-59.12pp
  • 20077.1%-24.80pp
  • 200631.9%+85.21pp
  • 2005-53.3%-40.00pp
  • 2004-13.3%+48.98pp
  • 2003-62.2%+596.72pp
  • 2002-659.0%-360.68pp
  • 2001-298.3%-240.25pp
  • 2000-58.0%-1.52pp
  • 1999-56.5%-21.97pp
  • 1998-34.6%-9.78pp
  • 1997-24.8%+95.14pp
  • 1996-119.9%-41.45pp
  • 1995-78.5%+39.64pp
  • 1994-118.1%+262.09pp
  • 1993-380.2%-212.36pp
  • 1992-167.8%-60.98pp
  • 1991-106.8%—

FCF Margin values are taken from Regeneron Pharmaceuticals's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About FCF Margin at Regeneron Pharmaceuticals (REGN)

According to Regeneron Pharmaceuticals's latest reported financial statements, the company's latest reported free cash flow margin is 27.9%. Free cash flow margin is free cash flow divided by revenue — the share of each sales dollar that converts into cash after capital expenditures. Because free cash flow cannot be inflated by non-cash accounting, FCF margin is a clean read on how efficiently a business turns revenue into deployable cash.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

In 2025, Regeneron Pharmaceuticals (REGN) free cash flow margin totalled 28.45% – expanded 2.6 percentage points year-over-year.

Across the available history, free cash flow margin reached its high of 40.63% in 2021 and its low of -658.96% in 2002.

Regeneron Pharmaceuticals FCF Margin by Year

Regeneron Pharmaceuticals FCF Margin 2025: 28.4%

Regeneron Pharmaceuticals free cash flow margin in 2025 was 28.45%, expanded 2.6 percentage points from 2024.

Regeneron Pharmaceuticals FCF Margin 2024: 25.8%

2024's free cash flow margin for Regeneron Pharmaceuticals came in at 25.80%, contracted 2.2 percentage points from 2023.

Regeneron Pharmaceuticals FCF Margin 2023: 28.0%

Regeneron Pharmaceuticals posted free cash flow margin of 27.96% in 2023, contracted 8.4 percentage points from 2022.

Regeneron Pharmaceuticals FCF Margin 2022: 36.3%

In 2022, Regeneron Pharmaceuticals reported free cash flow margin of 36.35%, contracted 4.3 percentage points from 2021.

Regeneron Pharmaceuticals FCF Margin 2021: 40.6%

Regeneron Pharmaceuticals free cash flow margin in 2021 was 40.63%.

See more financial history for Regeneron Pharmaceuticals (REGN).

Sector peers by FCF Margin

Healthcare peers of Regeneron Pharmaceuticals (REGN), ranked by their latest free cash flow margin

Frequently asked questions

Regeneron Pharmaceuticals (REGN) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation